[go: up one dir, main page]

PE20140424A1 - Gen sintetico para la expresion de sm14, en pichia pastoris, metodos para producir y purificar sm14 y el uso del mismo como vacuna y medio de diagnostico - Google Patents

Gen sintetico para la expresion de sm14, en pichia pastoris, metodos para producir y purificar sm14 y el uso del mismo como vacuna y medio de diagnostico

Info

Publication number
PE20140424A1
PE20140424A1 PE2013000517A PE2013000517A PE20140424A1 PE 20140424 A1 PE20140424 A1 PE 20140424A1 PE 2013000517 A PE2013000517 A PE 2013000517A PE 2013000517 A PE2013000517 A PE 2013000517A PE 20140424 A1 PE20140424 A1 PE 20140424A1
Authority
PE
Peru
Prior art keywords
expression
gene
pichia pastoris
vaccine
purify
Prior art date
Application number
PE2013000517A
Other languages
English (en)
Inventor
Miriam Tendler
Andrew J G Simpson
Ramos Celso Raul Romerp
Original Assignee
Ouro Fino Agronegocio Ltda
Fundacao Oswaldo Cruz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45830887&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20140424(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ouro Fino Agronegocio Ltda, Fundacao Oswaldo Cruz filed Critical Ouro Fino Agronegocio Ltda
Publication of PE20140424A1 publication Critical patent/PE20140424A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE REFIERE A UN GEN SINTETICO PARA LA EXPRESION DE Sm14, EN PICHIA PASTORIS, CUYO PROCEDIMIENTO DE PRODUCCION CONSISTE EN : A) SINTETIZAR UN GEN DEFINIDO POR SEQ ID NO: 3, B) CLONAR EL GEN SINTETIZADO EN EL VECTOR pPIC9K MEDIANTE EL SITIO DE bamHI Y RECONSTITUIR LA SECUENCIA DE KOZAK DEL GEN DE AOX1 ANTES DEL CODON DE INICIACION DE LA PROTEINA SM14, PARA LA EXPRESION DE SM14 EN SU FORMA INTRACELULAR, C) TRANSFORMAR P. PASTORIS CON EL PLASMIDO pPIC9K-Sm14-MV Y SELECCIONAR CLONES RECOMBINANTES CON MULTIPLES COPIAS. DICHO GEN ES UTIL EN EL TRATAMIENTO DE INFECCIONES CAUSADAS POR HELMINTOS.
PE2013000517A 2010-09-17 2011-09-13 Gen sintetico para la expresion de sm14, en pichia pastoris, metodos para producir y purificar sm14 y el uso del mismo como vacuna y medio de diagnostico PE20140424A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI1005855A BRPI1005855B1 (pt) 2010-09-17 2010-09-17 processos de produção e purificação de proteina sml 4 recombinante em pichia pastoris

Publications (1)

Publication Number Publication Date
PE20140424A1 true PE20140424A1 (es) 2014-03-28

Family

ID=45830887

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013000517A PE20140424A1 (es) 2010-09-17 2011-09-13 Gen sintetico para la expresion de sm14, en pichia pastoris, metodos para producir y purificar sm14 y el uso del mismo como vacuna y medio de diagnostico

Country Status (9)

Country Link
US (2) US9193772B2 (es)
EP (1) EP2617829B1 (es)
AU (1) AU2011301714B2 (es)
BR (1) BRPI1005855B1 (es)
MX (2) MX350668B (es)
NZ (1) NZ609370A (es)
PE (1) PE20140424A1 (es)
WO (1) WO2012034197A1 (es)
ZA (1) ZA201302741B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102017001309A2 (pt) * 2017-01-23 2018-08-14 Fundação Oswaldo Cruz vacina recombinante para helmintos em pichia pastoris, e, processos de produção e purificação de proteína como vacina para helmintos
CN112195192A (zh) * 2020-09-30 2021-01-08 贵州大学 一种利用酵母表达系统有效表达NaD1蛋白的方法
BR102021012953A2 (pt) 2021-06-29 2023-01-10 Fabp Biotech Desenvolvimento Em Biotecnologia Ltda. Composição de vacina veterinária contra helmintos, método para tratamento e prevenção de infecção causada por helmintos e uso

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0303266B8 (pt) * 2003-01-31 2021-05-25 Fundacao Oswaldo Cruz proteína recombinante sm14, composição imunogênica, e,kit de diagnóstico.

Also Published As

Publication number Publication date
MX350668B (es) 2017-09-12
EP2617829A4 (en) 2014-05-07
WO2012034197A8 (pt) 2012-06-07
ZA201302741B (en) 2018-12-19
WO2012034197A1 (pt) 2012-03-22
US9475838B2 (en) 2016-10-25
US9193772B2 (en) 2015-11-24
AU2011301714A1 (en) 2013-05-09
US20130237475A1 (en) 2013-09-12
MX339728B (es) 2016-06-06
BRPI1005855B1 (pt) 2020-04-22
EP2617829A1 (en) 2013-07-24
AU2011301714A8 (en) 2013-06-06
US20160052963A1 (en) 2016-02-25
BRPI1005855A2 (pt) 2013-01-15
MX2013003005A (es) 2013-10-03
NZ609370A (en) 2015-03-27
AU2011301714B2 (en) 2016-07-14
EP2617829B1 (en) 2019-08-28

Similar Documents

Publication Publication Date Title
AR117799A2 (es) Sal(es) de dimetil-amida del ácido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxílico y procesos para su elaboración
NZ628446A (en) Fibronectin based scaffold domain proteins that bind to myostatin
CY1120637T1 (el) Πολυπεπτιδικα αντισωματα που ανταγωνιζονται cd40
UY32633A (es) Anticuerpos humanizados específicos de la forma protofibrilar del péptido beta-amiloide
MX2015013711A (es) Novedosas n-acil-(3-sustituidas)-(8-sustituidas)-5,6-dihidro-[1,2, 4]triazolo[4,3-a]piracinas como antagonistas selecticos de receptor de nk-3, composicion farmaceutica y metodos para su uso en trastornos mediados por el receptor de nk-3.
MX347515B (es) Agentes que se unen al receptor encrespado y usos de los mismos.
MX385213B (es) Ligadores de nucleótidos modificados.
RU2021134101A (ru) Модифицированная j-цепь
UA111818C2 (uk) Антитіло проти csf-1r
PH12014502537A1 (en) Therapeutic uses of fibroblast growth factor 21 proteins
CL2017000774A1 (es) Método para producir gránulos de sulfato de potasio y el granulado de potasio derivado del mismo, así como también el uso del mismo.
MX2016011560A (es) Anticuerpos especificos para el receptor del factor de crecimiento similar a insulina 1 y usos de los mismos.
RU2015119517A (ru) Новый способ лечения инфаркта миокарда с применением фрагмента hmgb1
EA201491155A1 (ru) Новые мутантные про-нрф и их применение для получения бета-нрф
EA201592245A1 (ru) Устройство для приготовления раствора гидрокарбоната кальция, применимого для реминерализации воды
MX2016011557A (es) Anticuerpos especificos para el receptor del factor de crecimiento similar a insulina 1 y usos de los mismos.
CR20160048A (es) Polipéptidos cíclicos para el tratamiento de la insuficiencia cardiaca
EA201391171A1 (ru) Формы рифаксимина и их применение
ECSP15031046A (es) Polipéptidos estabilizados del factor de crecimiento tipo insulina
EA201492068A1 (ru) Гидрохлоридная соль пептида и ее применение в комбинации с другими пептидами в иммунотерапии
BR112015003957A2 (pt) alfa-1-microglobulina para uso no tratamento de doenças relacionadas com a mitocôndria
GB201110777D0 (en) Methods and uses
PE20140424A1 (es) Gen sintetico para la expresion de sm14, en pichia pastoris, metodos para producir y purificar sm14 y el uso del mismo como vacuna y medio de diagnostico
PL401631A1 (pl) Nowe kompleksy rutenu, sposób ich wytwarzania oraz ich zastosowanie
CL2015001881A1 (es) Compuesto 4-hidroxi-2-metil-5-(propan-2-iliden)ciclohexil-3-en-1-carbaldehido; uso del compuesto para el tratamiento de la enfermedad de alzheimer; composición farmacéutica; método para preparar la composición.

Legal Events

Date Code Title Description
FG Grant, registration